次世代シーケンシング(NGS)の世界市場:製品別(消耗品、プラットフォーム、およびサービス)、用途別(バイオマーカー・がん、診断、リプロダクティブヘルス、個別化医療、農業・動物研究、およびその他のアプリケーション)、技術別(合成シーケンス、イオン半導体シーケンス、ライゲーションシーケンス、パイロシーケンシング、単一分子リアルタイムシーケンス、およびその他の技術)、エンドユーザー別(学術・臨床研究センター、製薬・バイオテクノロジー企業、病院・診療所、その他のエンドユーザー)...市場調査レポートについてご紹介

【英文タイトル】Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms, and Services) Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Other End User): Global Opportunity Analysis and Industry Forecast, 2019–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective
2.2. Key findings

2.2.1. Top impacting factors
2.2.2. Top investment pockets

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Next generation sequencing Market

3.3.1. Moderate bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers

3.4. Pricing Analysis

3.4.1. Pricing Analysis, By Region, 2018 & 2026

3.5. Market Evolution
3.6. Value Chain Analysis
3.7. Impact of Government Regulations on Global Next Generation Sequencing Market
3.8. Patent Analysis (2016-2018)

3.8.1. Patent Analysis, by Year
3.8.2. By Country
3.8.3. By Applicant

3.9. Case Studies

3.9.1. Case Study 01

3.10. Market dynamics

3.10.1. Drivers

3.10.1.1. Technological advancements in NGS
3.10.1.2. Surge in applications of NGS
3.10.1.3. Increase in partnerships and collaborations
3.10.1.4. Increase in genome mapping programs

3.10.2. Restraints

3.10.2.1. Standardization concerns over NGS based diagnostics
3.10.2.2. Lack of skilled professionals
3.10.2.3. Ethical and legal limitations

3.10.3. Opportunities

3.10.3.1. Lucrative opportunities in emerging markets
3.10.3.2. Cloud computing: potential data management service

CHAPTER 4: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT

4.1. Overview
4.2. Market size and forecast
4.3. Consumables

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type

4.3.2.1. Sample preparation consumables

4.3.2.1.1. Market size and forecast, by type

4.3.2.1.1.1. DNA Fragmentation, End Repair, A-Tailing and Size Selection

4.3.2.1.1.1.1. Market size and forecast

4.3.2.1.1.2. Library preparation & target enrichment

4.3.2.1.1.2.1. Market size and forecast

4.3.2.1.1.3. Quality Control

4.3.2.1.1.3.1. Market size and forecast

4.3.2.2. Other Consumables

4.3.2.2.1. Market size and forecast

4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country

4.4. Platforms

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type

4.4.2.1. HiSeq series

4.4.2.1.1. Market size and forecast

4.4.2.2. MiSeq series

4.4.2.2.1. Market size and forecast

4.4.2.3. ION Torrent

4.4.2.3.1. Market size and forecast

4.4.2.4. SOLiD

4.4.2.4.1. Market size and forecast

4.4.2.5. Pacbio Rs II and Sequel system

4.4.2.5.1. Market size and forecast

4.4.2.6. Other Sequencing Platforms

4.4.2.6.1. Market size and forecast

4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country

4.5. Services

4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by type

4.5.2.1. Sequencing Services

4.5.2.1.1. Market size and forecast, by type

4.5.2.1.1.1. RNA Sequencing

4.5.2.1.1.1.1. Market size and forecast

4.5.2.1.1.2. Whole exome sequencing

4.5.2.1.1.2.1. Market size and forecast

4.5.2.1.1.3. Whole genome sequencing

4.5.2.1.1.3.1. Market size and forecast

4.5.2.1.1.4. Targeted sequencing

4.5.2.1.1.4.1. Market size and forecast

4.5.2.1.1.5. Chip sequencing

4.5.2.1.1.5.1. Market size and forecast

4.5.2.1.1.6. De Novo sequencing

4.5.2.1.1.6.1. Market size and forecast

4.5.2.1.1.7. Methyl sequencing

4.5.2.1.1.7.1. Market size and forecast

4.5.2.2. Data management services

4.5.2.2.1. Market size and forecast, by type

4.5.2.2.1.1. NGS Data Analysis Services

4.5.2.2.1.1.1. Market size and forecast

4.5.2.2.1.2. NGS data analysis software & workbenches

4.5.2.2.1.2.1. Market size and forecast

4.5.2.2.1.3. NGS storage, management, and cloud computing solutions

4.5.2.2.1.3.1. Market size and forecast

4.5.3. Market size and forecast, by region
4.5.4. Market analysis by country

CHAPTER 5: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION

5.1. Overview
5.2. Market size and forecast
5.3. Biomarkers and Cancer

5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country

5.4. Diagnostics

5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country

5.5. Reproductive Health

5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country

5.6. Personalized Medicine

5.6.1. Market size and forecast, by region
5.6.2. Market analysis by country

5.7. Agriculture and Animal Research

5.7.1. Market size and forecast, by region
5.7.2. Market analysis by country

5.8. Other Applications

5.8.1. Market size and forecast, by region
5.8.2. Market analysis by country

CHAPTER 6: NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

6.1. Overview
6.2. Market size and forecast
6.3. Sequencing by Synthesis (SBS)

6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country

6.4. Ion Semiconductor Sequencing (IOS)

6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country

6.5. Sequencing by Ligation (SBL)

6.5.1. Market size and forecast, by region
6.5.2. Market analysis by country

6.6. Pyrosequencing

6.6.1. Market size and forecast, by region
6.6.2. Market analysis by country

6.7. Single-Molecule-Real-Time Sequencing (SMRT)

6.7.1. Market size and forecast, by region
6.7.2. Market analysis by country

6.8. Other Technologies

6.8.1. Market size and forecast, by region
6.8.2. Market analysis by country

CHAPTER 7: NEXT GENERATION SEQUENCING MARKET, BY END USER

7.1. Overview
7.2. Market size and forecast
7.3. Academic and Clinical Research Centers

7.3.1. Market size and forecast, by region
7.3.2. Market analysis by country

7.4. Pharmaceutical and Biotechnology Companies

7.4.1. Market size and forecast, by region
7.4.2. Market analysis by country

7.5. Hospitals and Clinics

7.5.1. Market size and forecast, by region
7.5.2. Market analysis by country

7.6. Other End Users

7.6.1. Market size and forecast, by region
7.6.2. Market analysis by country

CHAPTER 8: NEXT GENERATION SEQUENCING MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends and opportunities
8.2.2. North America next generation sequencing market, by country

8.2.2.1. U.S. next generation sequencing market, by product
8.2.2.2. U.S. next generation sequencing market, by application
8.2.2.3. U.S. next generation sequencing market, by technology
8.2.2.4. U.S. next generation sequencing market, by end user
8.2.2.5. Canada next generation sequencing market, by product
8.2.2.6. Canada next generation sequencing market, by application
8.2.2.7. Canada next generation sequencing market, by technology
8.2.2.8. Canada next generation sequencing market, by end user
8.2.2.9. Mexico next generation sequencing market, by product
8.2.2.10. Mexico next generation sequencing market, by application
8.2.2.11. Mexico next generation sequencing market, by technology
8.2.2.12. Mexico next generation sequencing market, by end user

8.2.3. North America next generation sequencing market, by product
8.2.4. North America next generation sequencing market, by application
8.2.5. North America next generation sequencing market, by technology
8.2.6. North America next generation sequencing market, by end user
8.2.7. Europe
8.2.8. Key market trends and opportunities
8.2.9. Europe next generation sequencing market, by country

8.2.9.1. Germany next generation sequencing market, by product
8.2.9.2. Germany next generation sequencing market, by application
8.2.9.3. Germany next generation sequencing market, by technology
8.2.9.4. Germany next generation sequencing market, by end user
8.2.9.5. France next generation sequencing market, by product
8.2.9.6. France next generation sequencing market, by application
8.2.9.7. France next generation sequencing market, by technology
8.2.9.8. France next generation sequencing market, by end user
8.2.9.9. Italy next generation sequencing market, by product
8.2.9.10. Italy next generation sequencing market, by application
8.2.9.11. Italy next generation sequencing market, by technology
8.2.9.12. Italy next generation sequencing market, by end user
8.2.9.13. UK next generation sequencing market, by product
8.2.9.14. UK next generation sequencing market, by application
8.2.9.15. UK next generation sequencing market, by technology
8.2.9.16. UK next generation sequencing market, by end user
8.2.9.17. Rest of Europe next generation sequencing market, by product
8.2.9.18. Rest of Europe next generation sequencing market, by application
8.2.9.19. Rest of Europe next generation sequencing market, by technology
8.2.9.20. Rest of Europe next generation sequencing market, by end user

8.2.10. Europe next generation sequencing market, by product
8.2.11. Europe next generation sequencing market, by application
8.2.12. Europe next generation sequencing market, by technology
8.2.13. Europe next generation sequencing market, by end user

8.3. Asia-Pacific

8.3.1. Key market trends and opportunities
8.3.2. Asia-Pacific next generation sequencing market, by country

8.3.2.1. Australia next generation sequencing market, by product
8.3.2.2. Australia next generation sequencing market, by application
8.3.2.3. Australia next generation sequencing market, by technology
8.3.2.4. Australia next generation sequencing market, by end user
8.3.2.5. Japan next generation sequencing market, by product
8.3.2.6. Japan next generation sequencing market, by application
8.3.2.7. Japan next generation sequencing market, by technology
8.3.2.8. Japan next generation sequencing market, by end user
8.3.2.9. India next generation sequencing market, by product
8.3.2.10. India next generation sequencing market, by application
8.3.2.11. India next generation sequencing market, by technology
8.3.2.12. India next generation sequencing market, by end user
8.3.2.13. China next generation sequencing market, by product
8.3.2.14. China next generation sequencing market, by application
8.3.2.15. China next generation sequencing market, by technology
8.3.2.16. China next generation sequencing market, by end user
8.3.2.17. South Korea next generation sequencing market, by product
8.3.2.18. South Korea next generation sequencing market, by application
8.3.2.19. South Korea next generation sequencing market, by technology
8.3.2.20. South Korea next generation sequencing market, by end user
8.3.2.21. Taiwan next generation sequencing market, by product
8.3.2.22. Taiwan next generation sequencing market, by application
8.3.2.23. Taiwan next generation sequencing market, by technology
8.3.2.24. Taiwan next generation sequencing market, by end user
8.3.2.25. Rest of Asia-Pacific next generation sequencing market, by product
8.3.2.26. Rest of Asia-Pacific next generation sequencing market, by application
8.3.2.27. Rest of Asia-Pacific next generation sequencing market, by technology
8.3.2.28. Rest of Asia-Pacific next generation sequencing market, by end user

8.3.3. Asia-Pacific next generation sequencing market, by product
8.3.4. Asia-Pacific next generation sequencing market, by application
8.3.5. Asia-Pacific next generation sequencing market, by technology
8.3.6. Asia-Pacific next generation sequencing market, by end user

8.4. LAMEA

8.4.1. Key market trends and opportunities
8.4.2. LAMEA next generation sequencing market, by country

8.4.2.1. Brazil next generation sequencing market, by product
8.4.2.2. Brazil next generation sequencing market, by application
8.4.2.3. Brazil next generation sequencing market, by technology
8.4.2.4. Brazil next generation sequencing market, by end user
8.4.2.5. Saudi Arabia next generation sequencing market, by product
8.4.2.6. Saudi Arabia next generation sequencing market, by application
8.4.2.7. Saudi Arabia next generation sequencing market, by technology
8.4.2.8. Saudi Arabia next generation sequencing market, by end user
8.4.2.9. South Africa next generation sequencing market, by product
8.4.2.10. South Africa next generation sequencing market, by application
8.4.2.11. South Africa next generation sequencing market, by technology
8.4.2.12. South Africa next generation sequencing market, by end user
8.4.2.13. Rest of LAMEA next generation sequencing market, by product
8.4.2.14. Rest of LAMEA next generation sequencing market, by application
8.4.2.15. Rest of LAMEA next generation sequencing market, by technology
8.4.2.16. Rest of LAMEA next generation sequencing market, by end user

8.4.3. LAMEA next generation sequencing market, by product
8.4.4. LAMEA next generation sequencing market, by application
8.4.5. LAMEA next generation sequencing market, by technology
8.4.6. LAMEA next generation sequencing market, by end user

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Market Share Analysis of Top Players, 2018 (%)
9.3. Product Mapping of Top 10 Player

CHAPTER 10: COMPANY PROFILES

10.1. AGILENT TECHNOLOGIES, INC.

10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.1.6. Key strategic moves and developments

10.2. BEIJING GENOMICS INSTITUTE

10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product portfolio
10.2.5. Key strategic moves and developments

10.3. F. HOFFMANN-LA ROCHE LTD.

10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.3.6. Key strategic moves and developments

10.4. ILLUMINA, INC.

10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business Performance
10.4.6. Key strategic moves and developments

10.5. INTREXON CORPORATION (Intrexon Bioinformatics Germany GMBH)

10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business Performance

10.6. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product Portfolio
PacBio offers various NGS products through its services:
10.6.5. Business performance
10.6.6. Key strategic moves and developments

10.7. PERKINELMER, INC.

10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.7.6. Key strategic moves and developments

10.8. PIERIANDX

10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Key strategic moves and developments

10.9. QIAGEN N.V.

10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.9.6. Key strategic moves and developments

10.10. THERMO FISHER SCIENTIFIC, INC.

10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
10.10.6. Key strategic moves and developments


【レポート販売概要】

■ タイトル:次世代シーケンシング(NGS)の世界市場:製品別(消耗品、プラットフォーム、およびサービス)、用途別(バイオマーカー・がん、診断、リプロダクティブヘルス、個別化医療、農業・動物研究、およびその他のアプリケーション)、技術別(合成シーケンス、イオン半導体シーケンス、ライゲーションシーケンス、パイロシーケンシング、単一分子リアルタイムシーケンス、およびその他の技術)、エンドユーザー別(学術・臨床研究センター、製薬・バイオテクノロジー企業、病院・診療所、その他のエンドユーザー)
■ 英文:Next Generation Sequencing (NGS) Market by Product (Consumables, Platforms, and Services) Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Other End User): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年6月30日
■ 調査会社:Allied Market Research
■ 商品コード:AMR9AG056
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。